Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer

Oncotarget

Volumn 5, Issue 15, 2014, Pages 6206-6217

  Bilbao Sieyro, Cristina ^a,b   Ramírez Moreno, Raquel ^a,b   Rodríguez González, Germán ^a,b   Falcón, Orlando ^a,c   León, Laureano ^a,c   Torres, Santiago ^b   Fernández, Leandro ^a,d   Alonso, Sergio ^e   Díaz Chico, Nicolás ^a,b   Perucho, Manuel ^e,f,g   Díaz Chico, Juan Carlos ^a,b  

^a Madrid Spain   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^d UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^e Institute of Predictive and Personalized Medicine of Cancer IMPPC   (Spain)

^f BURNHAM INSTITUTE   (United States)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Aneuploidy; Endometrial cancer; Endometroid; Microsatellite instability; Survival

Indexed keywords

DNA;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DIPLOIDY; DISEASE FREE SURVIVAL; DNA ISOLATION; ENDOMETRIOID ENDOMETRIAL CANCER; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PLOIDY; PROGNOSIS; SALPINGOOOPHORECTOMY; SCORING SYSTEM; TREATMENT RESPONSE; CLASSIFICATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; GENETICS; SURVIVAL;

AGED; ANEUPLOIDY; CARCINOMA, ENDOMETRIOID; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MICROSATELLITE INSTABILITY; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84906271940     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2187     Document Type: Article

References (55)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: a cancer journal for clinicians. 2011; 61(4):212-236.
2. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecularbased classification. Virchows Archiv: an international journal of pathology. 2004; 444(3):213-223.
3. Prat J, Gallardo A, Cuatrecasas M, Catasus L. Endometrial carcinoma: pathology and genetics. Pathology. 2007; 39(1):72-87.
4. Susini T, Amunni G, Molino C, Carriero C, Rapi S, Branconi F, Marchionni M, Taddei G, Scarselli G. Tenyear results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. Cancer. 2007; 109(5):882-890.
5. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993; 260(5109):812-816.
6. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 1993; 363(6429):558-561.
7. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J. Genetic instability of microsatellites in endometrial carcinoma. Cancer research. 1993; 53(21):5100-5103.
8. Duval A, Collura A, Berthenet K, Lagrange A, Garrido C. Microsatellite instability in colorectal cancer: time to stop hiding! Oncotarget. 2011; 2(11):826-827.
9. Perucho M. Cancer of the microsatellite mutator phenotype. Biological chemistry. 1996; 377(11):675-684.
10. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2005; 23(3):609-618.
11. Rigas B, Borgo S, Elhosseiny A, Balatsos V, Manika Z, Shinya H, Kurihara N, Go M, Lipkin M. Decreased expression of DNA-dependent protein kinase, a DNA repair protein, during human colon carcinogenesis. Cancer research. 2001; 61(23):8381-8384.
12. Komuro Y, Watanabe T, Hosoi Y, Matsumoto Y, Nakagawa K, Tsuno N, Kazama S, Kitayama J, Suzuki N, Nagawa H. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer. 2002; 95(6):1199-1205.
13. Grabsch H, Dattani M, Barker L, Maughan N, Maude K, Hansen O, Gabbert HE, Quirke P, Mueller W. Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2006; 12(5):1494-1500.
14. Beggs AD, Domingo E, McGregor M, Presz M, Johnstone E, Midgley R, Kerr D, Oukrif D, Novelli M, Abulafi M, Hodgson SV, Fadhil W, et al. Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN. Oncotarget. 2012; 3(11):1348-1355.
15. Hawkins NJ, Tomlinson I, Meagher A, Ward RL. Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer. British journal of cancer. 2001; 84(2):232-236.
16. Chang SC, Lin JK, Yang SH, Wang HS, Li AF, Chi CW. Relationship between genetic alterations and prognosis in sporadic colorectal cancer. International journal of cancer Journal international du cancer. 2006; 118(7):1721-1727.
17. Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, French AJ, Laurie JA, Goldberg RM, Thibodeau SN, Witzig TE. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology. 2006; 131(3):729-737.
18. Duval A, Reperant M, Compoint A, Seruca R, Ranzani GN, Iacopetta B, Hamelin R. Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency. Cancer research. 2002; 62(6):1609-1612.
19. Woerner SM, Benner A, Sutter C, Schiller M, Yuan YP, Keller G, Bork P, Doeberitz M, Gebert JF. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes. Oncogene. 2003; 22(15):2226-2235.
20. Bilbao C, Ramirez R, Rodriguez G, Falcon O, Leon L, Diaz-Chico N, Perucho M, Diaz-Chico JC. Double strand break repair components are frequent targets of microsatellite instability in endometrial cancer. European journal of cancer. 2010; 46(15):2821-2827.
21. Basil JB, Goodfellow PJ, Rader JS, Mutch DG, Herzog TJ. Clinical significance of microsatellite instability in endometrial carcinoma. Cancer. 2000; 89(8):1758-1764.
22. MacDonald ND, Salvesen HB, Ryan A, Iversen OE, Akslen LA, Jacobs IJ. Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas. Cancer research. 2000; 60(6):1750-1752.
23. Maxwell GL, Risinger JI, Alvarez AA, Barrett JC, Berchuck A. Favorable survival associated with microsatellite instability in endometrioid endometrial cancers. Obstetrics and gynecology. 2001; 97(3):417-422.
24. Black D, Soslow RA, Levine DA, Tornos C, Chen SC, Hummer AJ, Bogomolniy F, Olvera N, Barakat RR, Boyd J. Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2006; 24(11):1745-1753.
25. Cohn DE, Frankel WL, Resnick KE, Zanagnolo VL, Copeland LJ, Hampel H, Kelbick N, Morrison CD, Fowler JM. Improved survival with an intact DNA mismatch repair system in endometrial cancer. Obstetrics and gynecology. 2006; 108(5):1208-1215.
26. Zighelboim I, Goodfellow PJ, Gao F, Gibb RK, Powell MA, Rader JS, Mutch DG. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2007; 25(15):2042-2048.
27. Suehiro Y, Okada T, Okada T, Anno K, Okayama N, Ueno K, Hiura M, Nakamura M, Kondo T, Oga A, Kawauchi S, Hirabayashi K, et al. Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation. Clinical cancer research: an official journal of the American Association for Cancer Research. 2008; 14(11):3354-3361.
28. Wik E, Trovik J, Iversen OE, Engelsen IB, Stefansson IM, Vestrheim LC, Haugland HK, Akslen LA, Salvesen HB. Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. American journal of obstetrics and gynecology. 2009; 201(6):603 e601-607.
29. Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene. 1998; 17(18):2413-2417.
30. McCourt CK, Mutch DG, Gibb RK, Rader JS, Goodfellow PJ, Trinkaus K, Powell MA. Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer. Gynecologic oncology. 2007; 104(3):535-539.
31. Malkhosyan SR, Yamamoto H, Piao Z, Perucho M. Late onset and high incidence of colon cancer of the mutator phenotype with hypermethylated hMLH1 gene in women. Gastroenterology. 2000; 119(2):598.
32. Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, Schaffer D, Samowitz WS. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer research. 2001; 61(1):126-130.
33. Yamashita K, Dai T, Dai Y, Yamamoto F, Perucho M. Genetics supersedes epigenetics in colon cancer phenotype. Cancer cell. 2003; 4(2):121-131.
34. Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD, Le Marchand L, Green RC, et al. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. Journal of the National Cancer Institute. 2010; 102(6):391-400.
35. Notarnicola M, Gristina R, Messa C, Cariola F, Fiorente P, Caruso ML, Gentile M, Di Leo A. Oestrogen receptors and microsatellite instability in colorectal carcinoma patients. Cancer letters. 2001; 168(1):65-70.
36. Walsh MD, Buchanan DD, Cummings MC, Pearson SA, Arnold ST, Clendenning M, Walters R, McKeone DM, Spurdle AB, Hopper JL, Jenkins MA, Phillips KD, et al. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clinical cancer research: an official journal of the American Association for Cancer Research. 2010; 16(7):2214-2224.
37. Kyushima N, Watanabe J, Hata H, Jobo T, Kameya T, Kuramoto H. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. Journal of cancer research and clinical oncology. 2002; 128(6):307-312.
38. An HJ, Kim KI, Kim JY, Shim JY, Kang H, Kim TH, Kim JK, Jeong JK, Lee SY, Kim SJ. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators. The American journal of surgical pathology. 2007; 31(6):846-853.
39. Zysman M, Saka A, Millar A, Knight J, Chapman W, Bapat B. Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype. Cancer research. 2002; 62(13):3663-3666.
40. Bilbao C, Rodriguez G, Ramirez R, Falcon O, Leon L, Chirino R, Rivero JF, Falcon O, Jr., Diaz-Chico BN, Diaz-Chico JC, Perucho M. The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer. International journal of cancer Journal international du cancer. 2006; 119(3):563-570.
41. Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri C, Dale D, Holowaty E, Bapat B, Gallinger S, Redston M. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer research. 1999; 59(14):3346-3351.
42. Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer research. 2000; 60(16):4366-4371.
43. Kloor M, Michel S, von Knebel Doeberitz M. Immune evasion of microsatellite unstable colorectal cancers. International journal of cancer Journal international du cancer. 2010; 127(5):1001-1010.
44. Risinger JI, Chandramouli GV, Maxwell GL, Litzi T, Berchuck A, Umar A. Gene expression analysis of tumor infiltrating lymphocyte markers in endometrial cancers indicates no significant increases in those cases with microsatellite instability. Cancer biomarkers: section A of Disease markers. 2006; 2(1-2):61-68.
45. Bilbao C, Lara PC, Ramirez R, Henriquez-Hernandez LA, Rodriguez G, Falcon O, Leon L, Perucho M, Diaz-Chico BN, Diaz-Chico JC. Microsatellite instability predicts clinical outcome in radiation-treated endometrioid endometrial cancer. International journal of radiation oncology, biology, physics. 2010; 76(1):9-13.
46. Colombino M, Cossu A, Manca A, Dedola MF, Giordano M, Scintu F, Curci A, Avallone A, Comella G, Amoruso M, Margari A, Bonomo GM, et al. Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2002; 13(9):1447-1453.
47. Negri FV, Campanini N, Camisa R, Pucci F, Bui S, Ceccon G, Martinelli R, Fumagalli M, Losardo PL, Crafa P, Bordi C, Cascinu S, et al. Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy. British journal of cancer. 2008; 98(1):143-147.
48. Zauber NP, Marotta SP, Berman E, Grann A, Rao M, Komati N, Ribiero K, Bishop DT. Molecular genetic changes associated with colorectal carcinogenesis are not prognostic for tumor regression following preoperative chemoradiation of rectal carcinoma. International journal of radiation oncology, biology, physics. 2009; 74(2):472-476.
49. Wang Q, Ponomareva ON, Lasarev M, Turker MS. High frequency induction of mitotic recombination by ionizing radiation in Mlh1 null mouse cells. Mutation research. 2006; 594(1-2):189-198.
50. Falcon O, Chirino R, Leon L, Lopez-Bonilla A, Torres S, Fernandez L, Garcia-Hernandez JA, Valeron PF, Diaz-Chico JC. Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer. British journal of cancer. 1999; 79(3-4):570-576.
51. Buhard O, Suraweera N, Lectard A, Duval A, Hamelin R. Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis. Disease markers. 2004; 20(4-5):251-257.
52. Perucho M. Correspondence re: C.R. Boland et al., A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 58: 5248-5257, 1998. Cancer research. 1999; 59(1):249-256.
53. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proceedings of the National Academy of Sciences of the United States of America. 1996; 93(18):9821-9826.
54. Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, Rognum TO, Esteller M, Lothe RA. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Molecular cancer. 2004; 3:28.
55. Deng G, Chen A, Hong J, Chae HS, Kim YS. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer research. 1999; 59(9):2029-2033.